The insider selling cluster is too small relative to market cap to warrant a bearish read-through. Monitor for any material increase in selling volume or a shift to C-suite selling at higher prices near $320.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Aug 10 $318.35entry
- T+1 · 3mo ago −1.77%α −1.45% · $312.72
- T+5 · 3mo ago −1.31%α −1.26% · $314.18
- T+20 · 2mo ago +3.22%α +4.13% · $328.59
- T+60 · 13d ago +22.13%α +24.03% · $388.80
Price Chart
How similar events traded
Executive Summary
A cluster of 7 Natera insiders, including the Executive Chairman, CEO, CFO, and President of Clinical Diagnostics, sold a total of ~$1.49M in open-market sales over a 7-day window ending August 7, 2026. While the cluster involves multiple C-suite executives, the total dollar value represents only ~0.004% of Natera's $38B market cap, making it trivial in proportion. The sales are likely driven by routine portfolio diversification or tax planning rather than a shared bearish view on the company's prospects, especially given the stock's strong performance and 87% analyst bullish consensus.
Key Financial Metrics
Key Facts
- 7 insiders sold shares totaling ~$1.49M in open-market transactions from Aug 3-7, 2026.
- Executive Chairman Matthew Rabinowitz sold 2,000 shares at $320.90 for $642K.
- CEO Steven Chapman sold 756 shares at ~$264-265 for ~$200K.
- CFO Michael Brophy sold 795 shares at ~$268-274 for ~$216K.
- Total insider sales represent ~0.004% of Natera's $38B market cap, well below the 0.1% materiality threshold.
- No insider purchases were reported in the cluster.
Financial Impact
Total insider sales of $1.49M represent 0.004% of market cap, economically trivial.
Risk Factors
- If selling volume increases significantly in coming weeks, it could signal a change in insider sentiment.
- The stock has rallied substantially (up ~16% in one prior window), and insiders may be taking profits near recent highs.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-NTRA-1786152945676 |
Track record
63 reports on NTRA
6 of 9 bullish or bearish reports moved the stock their way by T+1. Best: +6.55% at T+5 after the Oct 2, 2026 report. 6 of 9 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $300.44 Now $288.48 −3.98% settles Nov 17
- Nov 10, 20265d ago Insider Cluster Neutral 3/10 Entry $319.82 to $322.94 Now $288.48 −9.80% ▲ +0.98% +1.33% vs SPY
- Nov 10, 20265d ago S-3ASR Neutral 3/10 Entry $319.82 to $322.94 Now $288.48 −9.80% ▲ +0.98% +1.33% vs SPY
- Nov 6, 202610d ago SC 13G/A Neutral 3/10 Entry $310.67 to $320.39 Now $288.48 −7.14% ▲ +3.13% +0.76% vs SPY
- Nov 5, 202611d ago 8-K Mixed 6/10 Entry $310.67 to $320.39 Now $288.48 −7.14% ▲ +3.13% +0.76% vs SPY
- Nov 5, 202611d ago SC 13G Neutral 4/10 Entry $363.76 to $310.67 Now $288.48 −20.69% ▼ −14.59% −14.91% vs SPY
- Nov 4, 202611d ago Insider Cluster Neutral 2/10 Entry $363.76 to $310.67 Now $288.48 −20.69% ▼ −14.59% −14.91% vs SPY
- Nov 3, 202613d ago 144 Neutral 2/10 Entry $391.03 to $363.76 Now $288.48 −26.23% ▼ −6.97% −2.56% vs SPY
- Nov 2, 202614d ago 144 Neutral 2/10 Entry $388.63 to $391.03 Now $288.48 −25.77% ▲ +0.62% −1.03% vs SPY
- Nov 2, 202614d ago 144 Neutral 3/10 Entry $388.63 to $391.03 Now $288.48 −25.77% ▲ +0.62% −1.03% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers